Harry H. Penner, Jr.

Ticker

Position

Age

Qualifications and Experience

Committee Memberships

Filing Year

Ticker	Position	Age	Qualifications and Experience	Committee Memberships	Filing Year
CLDX	Director; Chair	80	["Chairman and Chief Executive Officer of Nascent BioScience, LLC from 2001 to June 2023","President, Chief Executive Officer and Vice Chairman of Neurogen Corporation from 1993 to 2001","Executive Vice President and General Counsel of Novo Nordisk A/S in Denmark from 1985 to 1988","Executive Vice President for North America of Novo Nordisk A/S from 1988 to 1993","Former Chair of BioCT","Former BioScience Advisor to the Governor and the State of Connecticut","Former Chair of Connecticut Technology Council","Former Chair of Connecticut Board of Governors of Higher Education","Currently Chair of NeuroCyte Therapeutics, Inc."]	[]	2026

HARRY H. PENNER, JR., 80

CARIEER HIGHLIGHTS

Chair since January 1997

AVANT Board and Chairman from January 1997 prior to the consummation of our merger with AVANT

PUBLIC BOARDS: 1

Nascent BioScience, LLC

Served as Chairman and Chief Executive Officer from 2001 to June 2023

COMMITTEES: None

Neurogen Corporation

President, Chief Executive Officer and Vice Chairman from 1993 to 2001

EDUCATION: B.A. from the University of Virginia, a J.D. from Fordham University, and an L.L.M. in International Law from New York University

Novo Nordisk A/S

Executive Vice President and General Counsel in Denmark from 1985 to 1988

Executive Vice President for North America from 1988 to 1993

BioCT

Former Chair

Former BioScience Advisor to the Governor and the State of Connecticut

Connecticut Technology Council

Former Chair

Connecticut Board of Governors of Higher Education

Former Chair

NeuroCyte Therapeutics, Inc.

Currently Chair

CELLDEX THERAPEUTICS INC (CLDX)